Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: gsk
Woman and Man Max 99 years
gsk
Update Il y a 5 ans
PGx7602: Pharmacogenetic Evaluation of FCGR Variation in patients treated with ofatumumab in study OMB110927
GlaxoSmithKline (GSK) is developing ofatumumab (GSK1841157), an anti-CD20 monoclonal antibody (mAb), for the treatment of multiple oncology indications, including chronic lymphocytic leukemia (CLL), f...
Country
None
organs
None
Specialty
None
Closed trial
More information
gsk
Update Il y a 5 ans
An Open-label, Single Dose, Three Session, Partially Randomized, Crossover Study to Assess Morning and Evening Dosing of Carvedilol Phosphate MR Capsules in Healthy Adult Subjects
Country
None
organs
None
Specialty
None
Closed trial
More information
gsk
Update Il y a 5 ans
A Study to Assess the Efficacy and Tolerability of Paroxetine by Double-Blind Comparison of Morning and Evening Doses in the Elderly
Country
None
organs
None
Specialty
None
Closed trial
More information
gsk
Update Il y a 5 ans
Incidence and Risk Factors for New-onset Diabetes in HIV-infected Patients. The Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study
Country
None
organs
None
Specialty
None
Closed trial
More information
gsk
Update Il y a 5 ans
Effects of Dopaminergic Agonist Treatment on Spinal Cord Excitability in Restless Legs Syndrome
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
gsk
Update Il y a 5 ans
An open-label, randomised, single-dose, multi-cohort, crossover bioavailability study of a solution formulation and three capsule formulations of GSK2190915 in healthy adult subjects followed by a repeat-dose, randomized, parallel group, double-blinded study of one selected capsule formulation and matched placebo in elderly healthy subjects
GSK2190915 is a high affinity 5-lipoxygenase-activating protein (FLAP) inhibitor that reduces inflammation in cells. This study will evaluate three capsule and two tablet formulations to select th...
Country
None
organs
None
Specialty
None
Closed trial
More information
gsk
Update Il y a 5 ans
A single dose study to compare the pharmacokinetics of ropinirole from three new formulations with the standard rmarketed reference formulation in healthy male volunteers and to assess the influence of food and domperidone on one of the new formulations
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
gsk
Update Il y a 5 ans
Determination of SPF, before and after (40 and 80 minutes) of immersion in water, for a cosmetic product
The Present study will determine the Sun Protection Factor (SPF) and will evaluate the resistance to water (after 40 and 80 minutes immersion) of the test product
Country
None
organs
None
Specialty
None
Closed trial
More information
gsk
Update Il y a 5 ans
Open study to further evaluate the safety, reactogenicity, and immunogenicity of GlaxoSmithKline Biologicals’ prophylactic herpes simplex candidate vaccine with gD-alum-MPL in HSV-1 and HSV-2 seronegative (HSV 1-/2-) women who previously received either alum-MPL or alum as placebo during one of GlaxoSmithKline Biologicals’ Phase III studies 208141/005 (HSV-007), 208141/016 (HSV-016) or 208141/017 (HSV-017)
Country
None
organs
None
Specialty
None
Closed trial
More information
gsk
Update Il y a 5 ans
Early use of Advair 250 within the COPD treatment paradigm
Country
None
organs
None
Specialty
None
Closed trial
More information
Previous
9
10
11
12
13
14
15
16
17
18
Next